Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia
- 1 July 1997
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 29 (1) , 16-22
- https://doi.org/10.1002/(sici)1096-911x(199707)29:1<16::aid-mpo3>3.0.co;2-v
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemiaCancer, 1995
- Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL XThe Lancet, 1995
- Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86Blood, 1994
- Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprechens in Blut und KnochenmarkKlinische Padiatrie, 1994
- Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.Journal of Clinical Pathology, 1992
- Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemiaBlood, 1991
- Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting featuresMedical and Pediatric Oncology, 1990
- Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.Journal of Clinical Oncology, 1989